Canada & Canada — Health Canada
29 shared events · Importance 5 · Last updated Aug 22, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
Canada: Canada is the country where the events occur, with its regulator and blood supply system involved. The pause does not affect the national blood supply.
Canada — Health Canada: Canada — Health Canada is the regulator that issued non-compliance ratings and imposed conditions on Grifols, leading to the pause. It is working to ensure compliance before allowing reopening.
Aug 13, 2026 · 6 articles
Business
Canada: Canada is now fully integrated into ClearPoint Neuro's global regulatory and clinical infrastructure, becoming a strategically important market for cell and gene therapy development.
Canada — Health Canada: Canada — Health Canada granted the Medical Device License to ClearPoint Neuro for its Neuro Navigation System, facilitating its use in Canadian neurosurgery centers.
Apr 20, 2026 · 6 articles
Tech
Canada: Canada>>> is a primary focus of this event, with oncologists like Jennifer L. Knox>>> and Daniel Renouf>>> working to open clinical trials for daraxonrasib to benefit Canadian pancreatic cancer patients.
Canada — Health Canada: Canada — Health Canada>>> has not yet received an application to license daraxonrasib in Canada>>>. Its role is to regulate and approve new drugs for use in the country, impacting the timeline for Canadian patient access.
May 29, 2026 · 74 articles
Business
Canada: Canada is the country where Medexus Pharmaceuticals has secured exclusive commercialization rights for Allogeneic umbilical cord-derived CD34- cells, non-expanded/dorocubicel, pending regulatory approval.
Canada — Health Canada: Canada — Health Canada is the regulatory body whose approval is required for Medexus Pharmaceuticals to begin commercializing Allogeneic umbilical cord-derived CD34- cells, non-expanded/dorocubicel in Canada.
Jun 10, 2026 · 6 articles
Regulatory
Canada: Canada is the country where the Canada — Health Canada licence was granted, enabling commercialization in the Canadian optometry market.
Canada — Health Canada: Canada — Health Canada granted a Class II medical device licence to Diagnosis for the CARA System, marking a regulatory approval.
Jul 27, 2026 · 6 articles
Regulatory
Canada: Canada is the market where Biocon's Yesintek autoinjector received approval, providing patients with a new biosimilar option for autoimmune diseases.
Canada — Health Canada: Canada — Health Canada granted Notice of Compliance for Biocon's Yesintek autoinjector, following earlier approvals for other formulations. The regulator's decision enables a new treatment option for Canadian patients.
Jul 29, 2026 · 6 articles
Regulatory
Canada: Canada is one of the initial markets where VueJect will be available following Canada — Health Canada authorization, potentially improving access to advanced cardiac imaging technology.
Canada — Health Canada: Canada — Health Canada authorized VueJect under Medical Device License No. 115637, permitting its sale in Canada.
Aug 11, 2026 · 7 articles
Business
Canada: Canada's regulatory environment, where ibogaine is not a controlled substance and Optimi Health has GMP infrastructure and Canada — Health Canada licensing, positions it as an advantageous base for ibogaine manufacture and supply.
Canada — Health Canada: Canada — Health Canada's regulation of ibogaine under the Food and Drugs Act and its listing on the Prescription Drug List provides a favorable regulatory environment for Optimi Health's operations.
Jun 08, 2026 · 14 articles
Business
Canada: Canada is the market where WYNZORA is launched, providing a new treatment option for psoriasis patients.
Canada — Health Canada: Canada — Health Canada approved WYNZORA in December 2025, a regulatory prerequisite for the launch.
Aug 20, 2026 · 6 articles
Business
Canada: Canada is the home country of MedMira, where its Multiplo Complete Syphilis Antibody Test is undergoing evaluation in multiple provinces and where Canada — Health Canada provides regulatory oversight.
Canada — Health Canada: Canada — Health Canada is the regulatory body providing initial feedback to MedMira regarding the approval process for its Multiplo Complete Syphilis Antibody Test.
Jun 30, 2026 · 6 articles
Accidents
Canada: Authorized Moderna's vaccine trial and restricted travel from DRC, contributing to global response.
Canada — Health Canada: Authorized Moderna's clinical trial, playing a regulatory role in vaccine development.
Aug 01, 2026 · 295 articles
Business
Canada: Canada, through Canada — Health Canada, contributes to the supportive regulatory environment in North America.
Canada — Health Canada: Canada — Health Canada provides supportive regulatory frameworks that facilitate product approvals and market growth in Canada.
Jul 28, 2026 · 6 articles
Business
Canada: Canada is the location of Optimi Health's GMP facility where the psilocybin products are manufactured and from where Canada — Health Canada issues export authorizations.
Canada — Health Canada: Canada — Health Canada issued the Drug Establishment Licence (DEL) to Optimi Health, authorizing the company's manufacturing, packaging, labeling, testing, storage, and distribution of controlled drug products.
Jun 02, 2026 · 25 articles
Business
Canada: Canada is the country where Optimi Health manufactures its psilocybin and MDMA products at its GMP facility and from where it exports these products internationally.
Canada — Health Canada: Canada — Health Canada issued the Drug Establishment Licence for Optimi Health's facility and the export authorization for the psilocybin shipment to Australia, regulating the production and export of these controlled substances.
Jun 29, 2026 · 12 articles
Business
Canada: Canada is Kane's home market and another key market where commercial activities have commenced following Canada — Health Canada approval.
Canada — Health Canada: Canada — Health Canada approval for Kane's products enables commercial sales in Canada, contributing to the company's market presence.
Aug 05, 2026 · 7 articles
Business
Canada: Canada>>> is the location of Diagnosis's headquarters and a target market for its regulatory clearances.
Canada — Health Canada: Diagnosis is pursuing regulatory clearance with Canada — Health Canada>>> for its CARA platform, a key milestone for market expansion in Canada.
Jun 05, 2026 · 11 articles
Regulatory
Canada: Canada is the home country of Canada — Health Canada; no direct impact from this announcement.
Canada — Health Canada: Canada — Health Canada provided scientific advice on the trial design, consistent with its regulatory role; no direct impact on the agency.
Jul 06, 2026 · 6 articles
Business
Canada: Canada is the market where Dell Technologies has specialized expertise in regulatory requirements, which Registrar Corp aims to leverage.
Canada — Health Canada: Canada — Health Canada regulations are a key area of Dell Technologies's expertise, which Registrar Corp will now offer to its clients.
Apr 16, 2026 · 6 articles
Business
Canada: Canada is the country where Lophos Holdings Inc. operates and where its regulatory bodies, Canada — Health Canada and the Canada — British Columbia Securities Commission, are located.
Canada — Health Canada: Canada — Health Canada is the issuer of the Controlled Substances Dealer's Licence that Lophos Pharmaceuticals Corporation previously held, impacting the company's ability to conduct controlled substance activities.
Jun 12, 2026 · 6 articles
Regulatory
Canada: Spectral Medical signed an exclusive distribution agreement for PMX in Canada.
Canada — Health Canada: Canada — Health Canada has licensed PMX for therapeutic use, indicating its approval in Canada.
Jun 25, 2026 · 6 articles
Regulatory
Canada — Health Canada: Canada — Health Canada issued a corresponding notice for the recall of Ryobi pressure washers in Canada, ensuring consumer safety in the region.
Aug 28, 2025 · 7 articles
Regulatory
Canada — Health Canada: Canada — Health Canada is the regulatory body in Canada to which Diagnosis plans to submit CARA for approval, impacting its commercialization in Canada.
Apr 08, 2026 · 6 articles
Domestic
Canada — Health Canada: Canada — Health Canada is the government agency responsible for drug approval processes in Canada. Bill C-286 seeks to streamline its Special Access Program for psilocybin and psilocin, which has been criticized for slow and unpredictable approvals.
Jun 16, 2026 · 6 articles
Tech
Canada — Health Canada: Canada — Health Canada has issued a Drug Establishment License (DEL) to Optimi Health Corp., allowing it to produce and distribute regulated psychedelic drug products.
Jun 16, 2026 · 11 articles
Tech
Canada — Health Canada: Canada — Health Canada approved the urgent application for exosome therapy on compassionate grounds, allowing the world-first treatment to proceed.
Jun 15, 2026 · 6 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Canada and Canada — Health Canada interact across events, view sentiment trends, and discover connected entities.
Open Dashboard